The 2 references without contexts in paper A. Petrov M., I. Stolyarov D., T. Gorokhova V., А. Петров М., И. Столяров Д., Т. Горохова В. (2015) “ТЕРИФЛУНОМИД В ТЕРАПИИ РЕМИТТИРУЮЩЕГО РАССЕЯННОГО СКЛЕРОЗА: ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ // TERIFLUNOMIDE IN TREATMENT OF REMITTING-RELAPSING MULTIPLE SCLEROSIS: EFFICACY AND SAFETY” / spz:neicon:nevro:y:2013:i:2:p:48-51

1
Сherwinski H.M., Cohn R.G., Cheung P. et al. The immunosuppressant lefl unomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis. J. Pharmacol. Exp. Ther. 1995;
(check this in PDF content)
3
Elder R.T., Xu X., Williams J.W. et al. The immunosuppressive metabolite of lefl unomide, A77 1726, affects murine T-cells through two biochemical mechanisms. J. Immunol. 1997; 159: 22—7.
(check this in PDF content)